Nuclear DNA fragmentation and expression of Bcl-2 in primary biliary cirrhosis

Abstract

It is uncertain whether or not apoptosis is involved in the pathogenesis of primary biliary cirrhosis (PBC). The aims of this study were to assess the nuclear DNA fragmentation and expression of Bcl‐2 in the biliary epithelial cells (BECs) and in the hepatocytes of PBC. Additionally, the effects of ursodeoxycholic acid (UDCA) on DNA fragmentation and Bcl‐2 expression in PBC were evaluated. Liver tissue specimens from 35 PBC patients were examined by in situ nick‐end labeling to detect any nuclear DNA fragments, and by immunohistochemistry for Bcl‐2. Ten of these patients underwent a second liver biopsy after the treatment with UDCA. Sixteen histologically normal liver tissues and 17 chronic viral hepatitis C (CVHC) samples were chosen as controls. DNA fragmentation in BECs was more frequently found in PBC than in CVHC and more frequently than in the normal controls (both P < .05), and fragmentation in the hepatocytes of PBC more frequently than in normal controls (P < .01). Bcl‐2 expression was more frequently found in both the BECs and hepatocytes of PBC than in the controls. UDCA significantly decreased the DNA fragmentation in BECs (P < .05) and the positivity for Bcl‐2 in BECs (P < .01), although no significant decrease was found in hepatocytes. In conclusion, de novo Bcl‐2 expression in hepatocytes of PBC was shown, and the increased nuclear DNA fragmentation and the Bcl‐2 expression both in BECs and in hepatocytes may reflect apoptotic stress, although nuclear DNA fragmentation in BECs did not necessarily represent apoptosis. UDCA showed a potential effect of reducing nuclear DNA fragmentation in BECs.